December 8, 2021

DBS of Thalamic Centromedian Nucleus for Lennox–Gastaut Syndrome (ESTEL Trial)

LDLinda J. DalicThe University of Melbourne AWAaron E. L. WarrenBrigham and Women's Hospital KBKristian BullussSt Vincent's Hospital

Key Points

Key points are not available for this paper at this time.

Abstract

CM-DBS in patients with LGS reduced electrographic rather than diary-recorded seizures, after 3 months of stimulation. Fifty percent of all participants had diary-recorded seizures reduced by half at the study exit, providing supporting evidence of the treatment effect. ANN NEUROL 2022;91:253-267.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Dalic et al. (Wed,) studied this question.

synapsesocial.com/papers/69db1cd0e6ab964fb0836d18 https://doi.org/https://doi.org/10.1002/ana.26280

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Peri‐lead edema after deep brain stimulation surgery for Parkinson's disease: a prospective magnetic resonance imaging study2018 · 46 citations
2Temporo-Spacial Correlations between Cortical and Subcortical EEG Spike-Wave Complexes of the Idiopathic Lennox-Gastaut Syndrome1998 · 12 citations
3Global assessment of the severity of epilepsy (GASE) Scale in children: Validity, reliability, responsiveness2015 · 74 citations
4Correlates of disability related to seizures in persons with epilepsy2015 · 64 citations
5Bilateral hippocampal stimulation for intractable temporal lobe epilepsy: Impact on seizures and memory2009 · 140 citations

Demander à l'IA

Bookmark

View Full Paper